View of ANALYZING PROGNOSTIC FACTORS OF RECURRENT/METASTATIC PULMONARY LARGE CELL NEUROENDOCRINE CARCINOMA PATIENTS TREATED WITH FIRST-LINE CISPLATIN PLUS ETOPOSIDE CHEMOTHERAPY

Return to Article Details ANALYZING PROGNOSTIC FACTORS OF RECURRENT/METASTATIC PULMONARY LARGE CELL NEUROENDOCRINE CARCINOMA PATIENTS TREATED WITH FIRST-LINE CISPLATIN PLUS ETOPOSIDE CHEMOTHERAPY Download Download PDF